Summary
The effect of aspirin on the in vivo formation of prostacyclin and thromboxane A2 in normal healthy individuals was studied by measuring the urinary excretion of 2,3-dinor-6-keto-PGF1α and 2,3-dinor-TxB2 by gas chromatography-mass spectrometry. Administration of 500 mg aspirin twice daily caused a sustained reduction in the excretion of 2,3-dinor-TxB2 to 10–15% of the predose value, while the excretion of 2,3-dinor-6-keto-PGF1α was reduced for only about 3 hours after the aspirin dose. The data demonstrate a considerable difference in the inhibitory effect of aspirin on the in vivo synthesis of thromboxane A2 and prostacyclin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Granström E, Diczfalusy U, Hamberg M (1983) The thromboxanes. In: Pace-Asciak C, Granström E (eds) Prostaglandins and related substances. Elsevier, Amsterdam, pp 45–94
Harker LA, Ritchie JL (1980) The role of platelets in acute vascular events. Circulation 62 [Suppl V]: 13–18
FitzGerald GA, Sherry S (1982) Pharmacology and pharmacokinetics of platelet-active drugs under current clinical investigation. In: Oates JA (ed) Prostaglandins and the cardiovascular system. Raven Press, NY, pp 107–172
Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994–2998
Roth GJ, Majerus PW (1975) The mechanism of the effect of aspirin on human platelets. J Clin Invest 56: 624–632
Johnson RA, Morton DR, Kinner JH, Gorman RR, McGuire JC, Sun FF, Whittaker N, Bunting S, Salmon J, Moncada S, Vane JR (1976) The chemical structure of prostaglandin X (prostacyclin). Prostaglandins 12: 915–928
Frölich JC, Rosenkranz B (1984) Measurements of eicosanoids: Analysis of prostacyclin. Prostaglandins 27: 354–355
FitzGerald GA, Pedersen AK, Patrono C (1983) Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 67: 1174–1177
Roberts LJ, Sweetman BJ, Oates JA (1981) Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem 256: 8384–8393
Rosenkranz B, Fischer C, Weimer KE, Frölich JC (1980) Metabolism of prostacyclin and 6-keto-prostaglandin F1α in man. J Biol Chem 21: 10194–10198
Vesterqvist O, Green K (1984) Urinary excretion of 2,3-dinorthromboxane B2 in man under normal conditions, following drugs and during some pathological conditions. Prostaglandins 27: 627–644
Vesterqvist O, Green K (1984) Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1α and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. Prostaglandins 28: 139–154
Zipser RD, Smorlesi C (1984) Regulation of urinary thromboxane B2 in man: Influence of urinary flow rate and tubular transport. Prostaglandins 27: 257–271
Vesterqvist O, Green K, Lincoln FH, Sebek OK (1983) Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determination of the daily urinary excretion rates in healthy humans. Thromb Res 33: 39–49
Rosenkranz B, Kitajima W, Frölich JC (1981) Relevance of urinary 6-keto-prostaglandin F1α determination. Kidney Int 19: 755–759
Burch JW, Stanford N, Majerus PW (1978) Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 61: 314–319
Burch JW, Baenziger NL, Stanford N, Majerus PW (1978) Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin. Proc Natl Acad Sci USA 75: 5181–5184
Jaffe EA, Weksler BB (1979) Recovery of endothelial prostacyclin production after inhibition by low doses of aspirin. J Clin Invest 63: 532–535
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vesterqvist, O. Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Eur J Clin Pharmacol 30, 69–73 (1986). https://doi.org/10.1007/BF00614198
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00614198